Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-induced osteomalacia: A systematic literature review.
Álvarez-Rivas N, Lugo-Rodríguez G, Maneiro JR, Iñiguez-Ubiaga C, Melero-Gonzalez RB, Iglesias-Cabo T, Carmona L, García-Porrúa C, de Toro-Santos FJ. Álvarez-Rivas N, et al. Bone Rep. 2024 May 8;21:101772. doi: 10.1016/j.bonr.2024.101772. eCollection 2024 Jun. Bone Rep. 2024. PMID: 38774264 Free PMC article. Review.
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.
Genre F, Prieto-Peña D, Pulito-Cueto V, Ocejo-Vinyals JG, Atienza-Mateo B, Muñoz Jiménez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galíndez-Agirregoikoa E, Calvo I, Ortego Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Llorente I, Blanco R, Gualillo O, Martín J, Castañeda S, López-Mejías R, Remuzgo-Martínez S, González-Gay MA. Genre F, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2023 Apr;41(4):910-915. doi: 10.55563/clinexprheumatol/cbjnmo. Epub 2023 Mar 2. Clin Exp Rheumatol. 2023. PMID: 36912345 Free article.
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.
Prieto-Peña D, Genre F, Pulito-Cueto V, Ocejo-Vinyals JG, Atienza-Mateo B, Muñoz Jiménez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galindez-Agirregoikoa E, Calvo I, Ortego Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Baldivieso-Achá JP, Blanco R, Gualillo O, Martín J, Castañeda S, López-Mejías R, Remuzgo-Martínez S, González-Gay MA. Prieto-Peña D, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2023 Apr;41(4):864-869. doi: 10.55563/clinexprheumatol/3cqh12. Epub 2022 Dec 5. Clin Exp Rheumatol. 2023. PMID: 36533991 Free article.
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586 Free article.
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.
Prieto-Peña D, Remuzgo-Martínez S, Genre F, Ocejo-Vinyals JG, Atienza-Mateo B, Muñoz-Jimenez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galíndez-Agirregoikoa E, Calvo I, Ortego-Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Llorente I, Blanco R, Gualillo O, Martín J, Márquez A, Castañeda S, Ferraz-Amaro I, López-Mejías R, González-Gay MA. Prieto-Peña D, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2022 May;40(4):727-733. doi: 10.55563/clinexprheumatol/8mku9c. Epub 2022 Mar 23. Clin Exp Rheumatol. 2022. PMID: 35349405 Free article.
Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals.
Prieto-Peña D, Remuzgo-Martínez S, Atienza-Mateo B, López-Mejias R, González-Gay MÁ; Spanish collaborative group for the study of large-vessel vasculitis. Prieto-Peña D, et al. Arthritis Res Ther. 2021 Oct 26;23(1):268. doi: 10.1186/s13075-021-02659-9. Arthritis Res Ther. 2021. PMID: 34702346 Free PMC article. No abstract available.
Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review.
Prieto-Peña D, Bernabeu P, Vela P, Narváez J, Fernández-López JC, Freire-González M, González-Álvarez B, Solans-Laqué R, Callejas Rubio JL, Ortego N, Fernández-Díaz C, Rubio E, García-Morillo S, Minguez M, Fernández-Carballido C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Manrique S, Romero-Gómez C, Moya P, Álvarez-Rivas N, Mendizabal J, Ortiz-Sanjuán F, Pérez de Pedro I, Alonso-Valdivielso JL, Perez-Sanchez L, Roldán R, Fernandez-Llanio N, Gómez de la Torre R, Suarez S, Montesa Cabrera MJ, Delgado Sánchez M, Loricera J, Atienza-Mateo B, Castañeda S, González-Gay MA, Blanco R. Prieto-Peña D, et al. Among authors: alvarez rivas n. Ther Adv Musculoskelet Dis. 2021 Jun 18;13:1759720X211020917. doi: 10.1177/1759720X211020917. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 34211589 Free PMC article.
The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Prieto-Peña D, Remuzgo-Martínez S, Ocejo-Vinyals JG, Atienza-Mateo B, Genre F, Muñoz-Jimenez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galindez-Agirregoikoa E, Calvo I, Ortego-Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Llorente I, García-García J, Blanco R, Gualillo O, Martin J, Castañeda S, Lopez-Mejías R, González-Gay MA. Prieto-Peña D, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):21-26. doi: 10.55563/clinexprheumatol/nn15lt. Epub 2021 Mar 18. Clin Exp Rheumatol. 2021. PMID: 33734973 Free article.
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients.
Calderón-Goercke M, Castañeda S, Aldasoro V, Villa I, Moriano C, Romero-Yuste S, Narváez J, Gómez-Arango C, Pérez-Pampín E, Melero R, Becerra-Fernández E, Revenga M, Álvarez-Rivas N, Galisteo C, Sivera F, De Miguel E, Prieto-Peña D, González-Gay MÁ, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Among authors: alvarez rivas n. Semin Arthritis Rheum. 2021 Apr;51(2):387-394. doi: 10.1016/j.semarthrit.2021.01.006. Epub 2021 Jan 27. Semin Arthritis Rheum. 2021. PMID: 33607384
Efficacy of belimumab in Primary Sjögren's syndrome: A systematic review.
Álvarez-Rivas N, Sang-Park H, Díaz Del Campo P, Fernández-Castro M, Corominas H, Andreu JL, Navarro-Compán V. Álvarez-Rivas N, et al. Reumatol Clin (Engl Ed). 2021 Mar;17(3):170-174. doi: 10.1016/j.reuma.2020.03.003. Epub 2020 May 22. Reumatol Clin (Engl Ed). 2021. PMID: 32451263 Free article. Review. English, Spanish.
15 results